Results 151 to 160 of about 8,712,867 (307)
Molecular Oncology, EarlyView.Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla +9 more
wiley +1 more source
Hijacking emergency granulopoiesis: Neutrophil ontogeny and reprogramming in cancer
Molecular Oncology, EarlyView.Neutrophils are highly plastic innate immune cells; their functions in cancer extend beyond the tumour microenvironment. This Review summarises current understanding of neutrophil maturation and heterogeneity and highlights tumour‐induced granulopoiesis as a systemic programme that expands immature, immunosuppressive neutrophils via tumour‐derived ...
Gabriela Marinescu, Yi Feng
wiley +1 more source
Forward march!: Woodland Cemetery Improvement Association moves forward ...
, 1940 Broadside issued by the Woodland Cemetery Improvement association, a group dedicated to maintaining the Black cemetery as a point of pride and respect. The broadside lists a membership fee of $5 to $100, and a list of officers of the association appears ...
Woodland Cemetery Improvement Association
core
Molecular Oncology, EarlyView.Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary +1 more
wiley +1 more source
Social care division/quality improvement division QI programme newsletter April 2016
, 2016 Programme newsletter for the social care division/quality improvement division quality improvement ...
National Quality Improvement Team
core
Molecular Oncology, EarlyView.This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska +13 more
wiley +1 more source
Balancing gain and diversity: Optimal contribution selection for sustainable genetic improvement in sugarcane. [PDF]
Plant GenomeVo Van-Zivkovic N +5 more
europepmc +1 more source
On the improvement of the population census
EKONOMISTIShelia, Mzia, Chelidze, Natia
openaire +1 more source
Molecular Oncology, EarlyView.Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source
Social care division/quality improvement division QI programme newsletter April 2017
, 2017 Programme newsletter for the social care division/quality improvement division quality improvement ...
National Quality Improvement Team
core